In a development aimed at reinforcing the United States' national security capabilities, ADDMAN Group, via its HARBEC business unit, has been entrusted with a pivotal qualification project for the US Navy.
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showing the performance of its Mercy Halo™ Ovarian Cancer screening test in a large cohort of asymptomatic, postmenopausal women.
Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product, NeuroQuant® v5.0, which is currently FDA 510(k) pending.
The Kansas Proving Grounds at Great Plains Industrial Park, a leading facility for testing and innovation, is proud to announce its partnership with SkyscoutAI Innovations Inc., a pioneer in AI-powered wildfire detection and response using drones and satellites.
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen the rigor and quality of patient-centered CER and a project to implement the findings of PCORI-funded research into practice.
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024.
SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami.
MSBAI, an Air Force Techstars 2020 company, today announced the successful completion of its AFWERX Phase 2 SBIR contract, titled GURU Owns the Modeling and Simulation Tech Stack.
a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that the company will be presenting its latest research results at both the Association for Research in Vision and Ophthalmology annual meeting, and at two meetings sponsored by the Ophthalmology Innovation Source (OIS) in early May.
Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at Prime Healthcare. The partnership allows EmVenio to conduct research at Prime Healthcare hospitals and offer Prime's patients improved access to clinical research.
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale study that revealed racial disparities in treatment, survival, and access to care among patients with metastatic castration-sensitive prostate cancer (mCSPC) since the first novel hormonal therapy was approved in 2018.
In March 2024, WCS trained 30 scientists from across the Coral Triangle in simple field methods to measure coral bleaching and identify climate resilient coral reefs.
Ferrum Health, the leading artificial intelligence platform for healthcare, is excited to announce that Gleamer's BoneView is now available to assist clinicians in the detection of bone trauma in Albuquerque, New Mexico.
Lipogems, a clinical stage- global medical technology company, announces it has completed enrollment in the ARISE I U.S. FDA IDE study, which aims to examine MicroFat versus corticosteriod injection for the treatment of Knee Osteoarthritis (OA). Efficacy and safety results from ARISE 1 are expected to be announced in 2025.
HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).
Factor Bioscience Inc. ("Factor"), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, today announced the addition of three members to its translational science team, which will be led by Kyle Garland, Ph.D., who joins Factor as Director of Translational Science.
Investigators from Analysis Group, a global leader in health economics and outcomes research (HEOR), the University of Oxford, and GSK have coauthored a pair of research papers that show that digital health technologies can continuously assess the symptoms of patients with rheumatoid arthritis (RA) in a remote setting.
Cole-Parmer, an Antylia Scientific company, is launching an all-new range of industry-leading fluid handling solutions initially comprised of tubing, fittings, parts, and accessories to suit a diverse array of research and production needs.
CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer.
Today, L-Nutra, the premier nutri-technology company, unveiled the results of a pioneering clinical trial, published in Diabetologia, which aims to redefine the approach to managing Type 2 Diabetes.
Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to enable the earliest detection of disease, are pleased to announce a strategic partnership aimed at advancing scientific discovery in the field of biofluid proteomics biomarkers.
The Children's Heart Foundation is proud to introduce the inaugural Underrepresented Minority in Medicine Research Training Award (URMRTA), an initiative aimed at supporting the career development of underrepresented minority individuals in pediatric cardiology research on congenital heart defects (CHDs).
Vee Technologies' extensive suite of healthcare business solutions is now rebranded as Vee Healthtek to emphasize its excellence in blending healthcare professional services and technology.
ProgenaCare Global™ has been awarded a national group purchasing agreement for Reconstructive Skin Grafting Products with Premier, Inc.
eXeX, a leader in artificial intelligence enhanced surgical logistics software, has achieved a world first by successfully utilizing the Apple Vision Pro in organizing and managing a Reverse Total Shoulder Arthroplasty.
The new company, led by a former executive from Foundation Medicine and Gritstone bio, is using advances in T-cell receptor repertoire analysis to reveal previously undetectable signals in standard liquid biopsy samples.
Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced its schedule of research presentations at the American Association for Cancer Research (AACR) annual meeting in San Diego, California, April 5-10, 2024.
The Osteopathic Center for Children & Osteopathy's Promise to Children is now looking for infants 4 months old and younger diagnosed with plagiocephaly (flat head syndrome), which affects 47% of infants in the US.
Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its esteemed Board of Directors.
Reportlinker announces the release of the report "A White Paper To Understand The Market Structure Of Pediatric Pertussis Hexavalent and Combination Vaccines".
Hundreds of millions of people around the world receive significant dental health benefits because their tap water is adjusted to the recommended amount of fluoride. Yet opponents of water fluoridation often cite a 2019 Canadian study (Green et al.) to claim that fluoride affects children's IQ scores.
Community Health Network, a leading provider of healthcare services in the state of Indiana, has announced an exciting partnership with Ferrum Health, a pioneer in healthcare artificial intelligence solutions aimed at enhancing patient care and outcomes through cutting-edge technology.
Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
Research conducted at the Phoenix Children's Research Institute at the University of Arizona College of Medicine — Phoenix reports the successful generation of a mouse lung in a rat, according to a paper published in the American Journal of Respiratory and Critical Care Medicine.
Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating the utilization of its Wharton's Jelly allografts in supplementing connective tissue defects associated with tarsal tunnel syndrome.
The Association for the Accreditation of Human Research Protection Programs has awarded full accreditation to Sitero IRB of Coral Gables, Florida.
Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an exclusive licensing agreement with Sovargen Co., Ltd, a biotechnology company specializing in central nervous system (CNS) diseases, to develop, manufacture and commercialise paxalisib as a potential treatment of intractable epilepsy in focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC) disease.
ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery in the biotech and pharma industries, announces the formation of its inaugural advisory board.
BOXABL is proud to announce significant progress in our Q1 2024 Update paired with the launch of our latest Factory Update Video #6.
Imagine being able to count the different types of blood cells being formed inside the tiny bones of a mouse and pinpointing the strings and clusters of cells within the bone marrow that are responsible for producing specific types of blood cells.
Remission Medical announced a partnership with Sentara Health to increase access to Rheumatology care for adult patients.
Babies with medical devices such as g-tubes, j-tubes, PICC lines, ports, and more often face challenges in finding suitable clothing that accommodates their needs.
It's National Sleep Awareness Month, and the American Massage Therapy Association (AMTA) is sharing the latest research on how massage can improve sleep quality.
Omeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today presented positive interim data from a diabetic foot ulcer (DFU) clinical trial showing that Omeza® OCM™ plus offloading of weight on the affected foot achieved a 91 percent area reduction (PAR) rate in DFUs within twelve weeks, and a 63 percent PAR within four weeks.
Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder's '3D Vaxlock' platform technology.
Radyus Research partners with Southern Research for an innovative alliance in the development of new drugs.
Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C.
It would be a game-changer if all members of a basketball team could see out of each other's eyes in addition to their own.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right